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An RNA ligase previously detected in extracts of Esch-
erichia coli is capable of joining Saccharomyces cerevi-
siae tRNA splicing intermediates in the absence of ATP
to form a 2*-5* phosphodiester linkage (Greer, C., Javor,
B., and Abelson, J. (1983) Cell 33, 899–906). This enzyme
specifically ligates tRNA half-molecules containing nu-
cleoside base modifications and shows a preference
among different tRNA species. In order to investigate
the function of this enzyme in RNA metabolism, the
ligase was purified to homogeneity from E. coli lysate
utilizing chromatographic techniques and separation of
proteins by SDS-polyacrylamide gel electrophoresis. A
single polypeptide of approximately 20 kilodaltons ex-
hibited RNA ligase activity. The amino terminus of this
protein was sequenced, and the open reading frame
(ORF) encoding it was identified by a data base search.
This ORF, which encodes a novel protein with a pre-
dictedmolecular mass of 19.9 kDa, was amplified from E.
coli genomic DNA and cloned. ORFs coding for highly
similar proteins were detected in Methanococcus jan-
naschii and Bacillus stearothermophilus. The chromo-
somal gene encoding RNA ligase in E. coli was dis-
rupted, abolishing ligase activity in cell lysates. Cells
lacking ligase activity grew normally under laboratory
conditions. However, moderate overexpression of the
ligase protein led to slower growth rates and a temper-
ature-sensitive phenotype in both wild-type and RNA
ligase knockout strains. The RNA ligase reaction was
studied in vitro using purified enzyme and was found to
be reversible, indicating that this enzyme may perform
cleavage or ligation in vivo.
RNA ligases have been detected in organisms throughout all
major divisions of the phylogenetic spectrum. Specific meta-
bolic functions, however, have been assigned to few of these
enzymes. T4 RNA ligase, for example, repairs nicks introduced
into the anticodon loops of tRNAs in phage-restrictive Esche-
richia coli strains upon T4 infection (1); the eukaryotic tRNA
splicing RNA ligase joins tRNA half-molecules resulting from
endonucleolytic removal of introns from eukaryotic tRNA pre-
cursors (2–4), and an RNA ligase is apparently responsible for
the joining of guide RNA molecules to mRNA during RNA
editing in kinetoplastids (5). At least two other species of RNA
ligase, the metazoan-specific “animal pathway” RNA ligase (6)
and the archaeal stable RNA splicing ligase (7), have been
identified, but the precise in vivo substrate(s) and function(s) of
these enzymes have yet to be determined.
The existence of RNA ligase in bacteria in the absence of
bacteriophage infection was discovered in this laboratory in
1983 (8). An activity capable of performing the ligation step of
eukaryotic tRNA splicing was detected in extracts of a wide
range of bacteria including members of the Alpha and Gamma
subdivisions of proteobacteria, green sulfur bacteria, and low G
1 C content Gram-positive bacteria (8). In extracts of E. coli
the ligase activity had a substrate specificity restricted to 4 of
the 10 Saccharomyces cerevisiae tRNA splicing intermediates:
tRNA Tyr, Phe, Lys2, and Trp half-molecules. The reaction
mechanism of the E. coli RNA ligase apparently differed from
that of known RNA ligases since it did not require a nucleoside
triphosphate cofactor, and the product contained an unusual
29-59 phosphodiester bond at the ligated junction (8).
The discovery of RNA ligase in E. coli implies the existence of
a novel form of bacterial RNA processing. No intervening se-
quences of the type found in eukaryotic nuclear or archaeal
tRNA genes (which require enzymatic excision and religation)
occur in known bacterial tRNA genes, although self-splicing
introns are found in the tRNA genes of certain cyanobacteria
(9) and some proteobacteria (10). In fact, no introns of any kind
are found in the full genomic complement of tRNA genes in E.
coli, Mycoplasma capricolum, and Hemophilus influenzae (11–
13). To date no RNA processing event that would require the
action of an RNA ligase enzyme has been observed to occur in
any bacteria, indicating that elucidation of the substrate and
function of the 29-59 RNA ligase should reveal a previously
unknown step in bacterial RNA metabolism.
A genuine in vivo function for the E. coli RNA ligase activity
observed in vitro is suggested by the occurrence of 29-59 link-
ages in native E. coli RNA. Several forms of 29-59-linked oli-
goadenylates have been detected in acid-soluble extracts of E.
coli (14). The most abundant species of these oligoribonucleo-
tides observed was 29-59-linked adenosine dinucleotide 39-
monophosphate, which was estimated to exist at an intracellu-
lar concentration over 100 nM. This dinucleotide could not be an
intermediate in oligoadenylate synthesis, and it has been sug-
gested that this species may be a degradation product of RNAs
containing individual 29-59 bonds among standard 39-59 link-
ages (14). Since the formation of 29-59 linkages is not catalyzed
by RNA polymerase, these bonds must be added in a post-
transcriptional processing event by an enzyme such as the 29-59
RNA ligase.
In order to study the function and mechanism of the 29-59
RNA ligase, the enzyme was purified to homogeneity from E.
coli extracts. A single polypeptide was found to contain RNA
ligase activity. This protein was partially sequenced, and the
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ORF1 encoding it was identified. This ORF was amplified from
E. coli genomic DNA and cloned. The chromosomal locus con-
taining the ligase gene was disrupted, abolishing ligase activity
in cellular extracts. Cells completely lacking ligase activity
grow similarly to the parent strain. E. coli strains overexpress-
ing recombinant 29-59 RNA ligase are temperature-sensitive for
growth. The ligase reaction was also studied using purified
enzyme and was found to be reversible in vitro.
EXPERIMENTAL PROCEDURES
Strains—E. coli strains utilized were HB101, XL1-Blue (Novagen),
and HSD947, DH10B, RecA1.
Preparation of RNA Substrates for Ligation—RNA polymerase III
transcription of pre-tRNATyr in yeast extract was performed by the
method of Evans and Engelke (15), using extracts prepared as de-
scribed. The template for Pol III transcription of pre-tRNATyr was
supercoiled pYSUP6 (16). T7 RNA polymerase transcription was per-
formed as described by Sampson and Saks (17). pre-tRNAPhe was tran-
scribed from the artificial pre-tRNA gene of Reyes cloned into pUC13
(18). The template for pre-tRNATyr T7 transcription was created by
PCR amplification from pYSUP6, adding a canonical T7 promoter at the
59 end and a BstNI restriction site at the 39 end of the pre-tRNA, as well
as altering the acceptor stem base pairs: C13 G, T23 G, A873 C, and
G883 C to improve transcription yields. This construct was cloned into
the pBlueScript vector (Stratagene). tRNA substrates were modified by
incubation at 24 °C for 45 min in the same extract and reaction condi-
tions as were used for Pol III transcription. tRNA precursors were
cleaved as described by Peebles et al. (2), using partially purified S.
cerevisiae tRNA splicing endonuclease fractions from the hydroxyapa-
tite step or later as described in the Rauhut protocol (2, 19).
All RNA transcripts were gel purified by polyacrylamide gel electro-
phoresis (PAGE) in 1 3 TBE (Tris borate EDTA buffer), 7 M urea and
visualized by autoradiography. RNAs were eluted from crushed gel
slices in 0.6 M NH4OAc, 2 mM EDTA, 0.005% Nonidet P-40 at room
temperature with vortexing for 20 min. RNA eluates were extracted
with phenol/chloroform (1:1, pH 4.5) and chloroform and then ethanol-
precipitated in the presence of glycogen and resuspended in distilled
water.
RNA Ligation Assay—tRNA half-molecules were annealed for liga-
tion in 2 3 ligation buffer (1 3 5 40 mM HEPES, pH 7.8, 3 mM MgCl2,
2 mM spermidine, 5% glycerol) by heating to 85 °C and slowly cooling to
30 °C over 20 min. Ligation reactions were typically performed in 4 ml
of 1 3 ligation buffer with 250 nM annealled tRNA half-molecules
substrate. E. coli lysates or purification fractions (typically 1 ml) were
added and incubated for 2–5 min at 30 °C. Reactions were stopped by
the addition of 1.5 mg/ml proteinase K, 0.04% SDS, 5 mM EDTA, and
0.001 mg/ml E. coli total RNA for 20 min at 30 °C. An equal volume of
90% deionized formamide plus tracking dyes was added, and reactions
were incubated at 65 °C for 5 min before cooling on ice and loading onto
8% acrylamide, 7 M urea, 1 3 TBE gels for electrophoresis. RNA bands
were visualized by autoradiography or by exposure to a Molecular
Dynamics storage phosphor plate for quantification and analysis on a
PhosphorImager using Imagequant software.
Large-scale Cell Growth—Cells were grown in media containing 16
g/liter Bacto-tryptone, 6 g/liter yeast extract, 50 mM phosphate buffer,
pH 6.8, 4 g/liter (NH4)2SO4, 0.5 g/liter MgSO4 (anhydrous), and 20
ml/liter glycerol with aeration and constant feeding of 2 3 media for
24 h. 5%methanol (which was found to induce ligase activity in extracts
to approximately 1.5 3 that found in extracts of uninduced cells) was
added to media 2 h before harvest, and harvested cell paste was stored
at 270 °C.
E. coli RNA Ligase Purification—All purification procedures were
performed in extraction buffer (EB) containing 10% glycerol, 40 mM
HEPES, pH 7.8, 2 mM EDTA, 1 mM Pefabloc (Boehringer Mannheim), 1
mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, and stated con-
centrations of KCl. 200 g to 1 kg of HB101 cells frozen at 270 °C were
thawed in a final volume of 1.6 ml/g cells of EB plus 125 mM KCl and
dispersed with a hand blender. The cell suspension was sonicated on ice
with a Branson Sonifier large tip at 80% power for 15 1-min periods
with cooling on ice between. Cell lysate was centrifuged at 35,000 rpm
in a Beckman 45Ti rotor at 3 °C for 1 h. The supernatant was mixed
batchwise with 500 ml of DEAE-Sepharose CL-6B (equilibrated in EB
1 125 mM KCl) for 30 min on ice. All subsequent steps were performed
at 4 °C. The DEAE/extract slurry was poured into a column, and the
DEAE effluent was loaded at approximately 1 ml/min onto a 200-ml bed
of cellulose phosphate P11 (Whatman) equilibrated in EB 1 125 mM
KCl.
The phosphocellulose column was washed extensively with EB 1 500
mM KCl and eluted with a linear KCl gradient from 0.5 to 1.5 M in EB.
Peak ligase activity fractions were pooled, diluted to 150 mM KCl, and
loaded onto 25 ml of heparin Hyper-D (Biosepra) column. Ligase activ-
ity was eluted from the heparin column with a 150–700 mM KCl
gradient in EB, and peak fractions were pooled. The heparin pool was
diluted to 150 mM KCl in EB and loaded onto a 15-ml bed column of E.
coli tRNA linked to a Sepharose support. tRNA Sepharose (3 mg of RNA
per ml of gel) was prepared as described by Rauhut et al. (19) but using
E. coli tRNA (Sigma) instead of yeast tRNA. Ligase was eluted from this
column using a gradient from 150 mM to 1 M KCl in EB, followed by a
2 M KCl wash. The ligase eluted in a broad peak beginning around 400
mM KCl, trailing into the 2 M wash.
Active fractions were pooled, diluted to 150 mM KCl, loaded onto a
2-ml column of heparin hyper-D, and eluted with EB 1 600 mM KCl.
This concentrated activity pool was then passed through a 115-ml bed
of Superdex 75 gel filtration medium (Pharmacia Biotech Inc.) at a flow
rate of 0.04 ml/min. Peak active fractions were diluted to 150 mM KCl in
EB and loaded onto a column of S. cerevisiae tRNA linked to Sepharose
(19). Ligase activity was eluted with a 150–800 mM KCl gradient. Note:
For the 4-kg preparative purification mentioned under “Results,” the
purification procedure followed was the same as described above except
that an S. cerevisiae tRNA affinity column was substituted for the
initial E. coli tRNA step, and the tRNA pool was passed through
Superdex 75 twice, sequentially.
SDS-PAGE, Elution, and Renaturation—Electrophoresis for prepar-
ative elution, as well as all analytical protein electrophoresis, was
performed on 16% acrylamide/piperazine diacrylamide (2.67% cross-
linking) gels under the conditions of Schagger et al. (20). Bands were
visualized by staining with 0.3 M CuCl2 for 15 min at room temperature,
excised, and destained by successive washes in 0.25 M Tris-HCl, pH 8.8,
0.25 M EDTA, and distilled water. Excised bands were crushed and
extracted overnight at 4 °C in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl,
0.1% SDS, and 0.1 mg/ml acetylated bovine serum albumin (Life Tech-
nologies, Inc.). Eluted protein was precipitated with 4 volumes of cold
acetone, incubated for 30 min at 0 °C, and pelleted by centrifugation at
15,000 rpm, 4 °C, for 20 min in an SS-34 rotor. Pellets were resus-
pended in EB containing 6 M guanidine HCl and microdialyzed versus
EB plus 125 mM KCl at 4 °C. Silver staining of SDS-PAGE gels was
performed according to the method of Wray et al. (21).
PCR—PCR was performed in 1 3 PCR buffer with Mg21 (Boehringer
Mannheim), 0.4 mM dATP, dCTP, dGTP, and dTTP, 10 mM each oligo-
nucleotide primer, and 0.7 units/ml Taq DNA polymerase. For reactions
using degenerate primers, 400 mM total primers was used. For labeled
probe production, 300 mM dCTP, dGTP, and dTTP were used in the
presence 1 mM [a-32P]dATP (Amersham Corp., 3000 Ci/mmol).
Mapping Blot Hybridization—Labeled PCR product was heated to
95 °C in 6 3 SSC, 10 mM phosphate buffer, pH 6.8, 1 mM EDTA, 0.5%
SDS, 100 mg/ml sonicated calf thymus DNA, and 0.1% dry milk, and
then cooled on ice. The probe was hybridized to an E. coliGene Mapping
Membrane (PanVera) in the same buffer at 37 °C, overnight. The blot
was washed with 6 3 SSC, 0.1% SDS, and with 5 3 SSC at room
temperature and then exposed to film for autoradiography.
Genomic Knockout—The E. coli RNA ligase gene was cloned by PCR
amplification from HB101 genomic DNA using primers corresponding
to sequences located 213 bp upstream of the 59 end and at the exact 39
end of the predicted ORF, adding EcoRI and BamHI restriction sites,
respectively. Gene disruption was performed according to the method of
Hamilton et al. (22). For genomic disruption, the Kanr Genblock (Phar-
macia) cassette was inserted into a PstI site located at 1144 bp in the
ligase ORF clone. A ts plasmid bearing the interrupted ligase gene was
created as follows. The origin-bearing PvuII fragment of pFC20 (23) (bp
950-3838) was cloned into pMAK705 (22), replacing the PvuII fragment
spanning bp 5458–3722. The Kan cassette-interrupted ligase gene was
then subcloned into the EcoRI-BamHI sites of the pMAK polylinker in
this construct to create pTSIL. pTSIL was transformed into a RecA1
strain of E. coli (HSD947) and plated at 43 °C on chloramphenicol to
select for cointegration into the chromosome. Plasmid cointegrants
were resolved by growth for several generations in liquid culture at
30 °C, at which temperature the plasmid replicon interferes with chro-
mosomal replication. The chromosomal recA locus was then disrupted
by P1 phage transduction to prevent further homologous recombination
1 The abbreviations used are: ORF, open reading frame; PCR, polym-
erase chain reaction; PAGE, polyacrylamide gel electrophoresis; PNK,
polynucleotide kinase; pre-tRNA, intron-containing tRNA precursor;
bp, base pair(s); ts, temperature-sensitive; kbp, kilobase pair(s).
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events. Cointegrant cultures were pelleted and resuspended in 0.1 M
MgSO4, 5 mM CaCl2 and mixed with an equal volume of P1 lysate
JC102402 for 20 min at 30 °C and plated on LB 1 tetracycline, chlor-
amphenicol, and kanamycin to select for transductants. P1 transduc-
tants were screened for resolution of the ts plasmid by streaking sepa-
rately on chloramphenicol, kanamycin, and nonselective LB plates at
43 °C.
RESULTS
E. coli 29-59 RNA Ligase Requires Base Modifications in
tRNA Substrates—In previous studies of bacterial RNA ligase,
activity had been assayed using substrates derived from tRNA
precursors (pre-tRNAs) transcribed either in vivo in yeast or by
endogenous RNA polymerase III activity in an S. cerevisiae
extract (8). It was subsequently reported that pre-tRNAPhe
transcribed from an artificial tRNAPhe gene by T7 RNA polym-
erase is an excellent substrate for the S. cerevisiae tRNA splic-
ing enzymes (18), and this was also tested for ligation by E. coli
RNA ligase. tRNAPhe half-molecules produced by digestion of
T7-transcribed pre-tRNAPhe with S. cerevisiae tRNA splicing
endonuclease were, however, poorly ligated in E. coli extracts
(data not shown). Since tRNAPhe half-molecule substrates pro-
duced in vivo in yeast had previously been demonstrated to be
ligated in E. coli extract (8), a requirement for some modifica-
tion of substrate transcripts was implied.
In order to test the putative modification requirement, an S.
cerevisiae tRNATyr gene was cloned under the control of a T7
RNA polymerase promoter. tRNATyr half-molecules derived
from unmodified transcripts of this gene were poor substrates
for the E. coli ligase, although they were utilized effectively by
the S. cerevisiae tRNA splicing ligase. Fig. 1A shows that when
pre-tRNATyr transcripts (lane M) were incubated in the same
S. cerevisiae extracts utilized for RNA polymerase III tran-
scription, tRNATyr half-molecules derived from them (lane 1)
became substrates for the E. coli RNA ligase (lane 4). E. coli
RNA ligase ligation of half-molecules derived from pre-tRNATyr
modified in vitro produced a product of equivalent size to that
produced by S. cerevisiae tRNA ligase or T4 RNA ligase and
polynucleotide kinase (PNK) (lanes 2–3), although the bacterial
enzyme is less efficient at joining these substrates. tRNA half-
molecule substrates derived from modified T7 RNA polymerase
transcripts were utilized by the E. coli RNA ligase as efficiently
as yeast polymerase III transcripts, as quantified in a substrate
titration experiment shown in Fig. 1B. This was presumably
due to the formation of modified nucleosides in these tran-
scripts, as observed by two-dimensional thin layer chromatog-
raphy (TLC) of nuclease digests of substrate transcripts (data
not shown). The identity and location of these modifications
were not investigated further. The presence of a 29-59 linkage in
ligated tRNA products was also observed by nuclease digestion
and TLC (not shown), confirming that the reaction had been
catalyzed by the previously described E. coli 29-59 ligase
activity.
Pre-tRNAPhe T7 RNA polymerase transcripts modified by
incubation in yeast extract were also used to produce sub-
strates for ligation by the E. coli enzyme, although modified
tRNATyr half-molecules were preferred as substrates by a fac-
tor of 2–3-fold over modified tRNAPhe half-molecules (Fig. 1C).
Because tRNATyr half-molecules produced by endonuclease di-
gestion of T7-transcribed, yeast extract-modified pre-tRNATyr
were the most active substrates tested for ligation by the E. coli
RNA ligase, they were chosen as substrates for quantitative
assays of ligase activity during subsequent procedures.
Purification of the Ligase—A protocol for purification of the
E. coli RNA ligase was developed and followed as detailed
under “Experimental Procedures.” A quantitative profile of
RNA ligase activity throughout the purification procedure is
given in Table I. The complexity of the protein population at
each purification step was assayed by SDS-PAGE and silver
staining and is shown in Fig. 2. Briefly, cells were disrupted by
sonication, and the lysate (Fig. 2, lane 1) was subjected to2 M. Saks, personal communication.
FIG. 1. Ligation of tRNA half-molecule substrates. A, ligation of
tRNATyr half-molecules derived from T7-transcribed, yeast-modified
ptRNATyr as described under “Experimental Procedures.” Reactions
including 0.35 pmol of half-molecules were incubated at 30 °C for 2 min
and stopped to observe ligation rate. Reactions were supplemented with
H2O (lane 1), T4 RNA ligase, PNK, and ATP (lane 2), S. cerevisiae tRNA
ligase and ATP (lane 3), and E. coli extract (lane 4). The location of
pre-tRNATyr (lane M), Tyr halves, and ligated products are indicated. B,
titration of tRNATyr half-molecule substrates for ligation in E. coli
extract. The indicated molar amounts of tRNATyr half-molecules were
incubated with 1 ml of E. coli lysate each at 30 °C for 15 min. Half-
molecule substrates were derived from pre-tRNATyr: transcribed by T7
RNA polymerase (j), transcribed by yeast RNA polymerase III in yeast
extract (M), or transcribed by T7 polymerase and subsequently incu-
bated in yeast extract (f). C, titration of tRNATyr and tRNAPhe half-
molecule substrates for ligation. tRNAPhe half-molecules (E) and tRNA-
Tyr half-molecules (M) were derived from T7-transcribed, yeast-modified
pre-tRNAs. The indicated molar amounts of substrate were incubated
with 0.5 ml of partially purified E. coli RNA ligase (cellulose phosphate
pool, see below) for 2 min at 30 °C.
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centrifugation at 100,000 3 g. The S-100 supernatant (lane 2)
was mixed batchwise with a DEAE anion-exchange resin, and
the unbound fraction (lane 3) was loaded onto a cellulose phos-
phate column. RNA ligase activity was eluted from the cellu-
lose phosphate by an increasing gradient of KCl, and fractions
containing peak levels of RNA ligase activity were pooled for
further purification by sequential binding to, and salt gradient
elution from, heparin and E. coli tRNA affinity matrices.
Pooled active fractions were subjected to gel filtration through
Superdex 75 media. Peak RNA ligase activity fractions after gel
filtration contained a mixture of at least six polypeptides (Fig.
2, lane 8). Superdex 75 peak fractions were then pooled for
binding to a column of S. cerevisiae tRNA-Sepharose. RNA
ligase activity eluted from this matrix with a salt gradient still
contained several polypeptide species (lane 9).
Reconstitution of Ligase Activity from a Single Polypeptide
Following SDS-PAGE—Since the optimized purification proce-
dure did not yield a single homogeneous polypeptide, separa-
tion by denaturing electrophoresis was also utilized. A large
scale purification was undertaken using 4 kg of E. coli cells as
starting material. Final peak ligase activity fractions were
pooled and concentrated by dialysis, and an aliquot of the
concentrate was subjected to SDS-PAGE. Successive regions of
the SDS-PAGE gel lane were excised and individually ex-
tracted. Eluted protein from each gel slice was precipitated and
resuspended in guanidine HCl. After dialysis, eluates were
assayed for RNA ligase activity (Fig. 3A) and examined by
SDS-PAGE (Fig. 3B). Only a single eluate showed significant
reconstituted activity (Fig. 3A, lane 5). The level of RNA ligase
activity in this eluate was not affected by mixing with eluates
of other gel slices (not shown). Fig. 3B shows that the active
eluate contains only a single E. coli protein (of approximately
20 kDa) in addition to the bovine serum albumin carrier pro-
tein added during extraction (compare lane 5 to lane 2). A small
amount of a polypeptide of about 20 kDa is present in the low
molecular weight eluate (Fig. 3B, lane 3) which may explain
the trace ligase activity observed in this fraction (Fig. 3A, lane
3). Due to its ability to reconstitute RNA ligase activity, the
20-kDa protein alone was presumed to be the E. coli RNA
ligase.
Ligase Protein Sequencing and Identification of the RNA
Ligase Gene—A second aliquot of the concentrated RNA ligase
activity pool was subjected to SDS-PAGE and transferred to a
nylon membrane, from which individual protein bands were
excised for sequencing. 15 residues of amino-terminal sequence
of the 20-kDa RNA ligase protein were obtained and are given
in Fig. 4A. This sequence did not match any known protein or
predicted ORF in the then current Genbank/EMBL data bases.
A set of degenerate oligonucleotide primers corresponding to
possible coding sequences for an internal segment of the amino-
terminal sequence (shown in Fig. 4A) was synthesized for use
in PCR. Fig. 4B shows that these oligonucleotides successfully
amplified a DNA fragment of approximately 55 bp from E. coli
cells or genomic DNA (lanes 1 and 2) but produced no product
using S. cerevisiae cells as a template, or in reactions lacking
either primers or template (lanes 3–5). The amplified DNA was
cloned and sequenced.
In order to facilitate the cloning of the E. coli RNA ligase
gene, its chromosomal location was determined using a
genomic mapping blot. A radiolabeled DNA probe was created
by PCR using the degenerate primers described above and
hybridized to a membrane containing the Kohara “mini-set” of
ordered, overlapping E. coli genomic phage clones (24). Hybrid-
TABLE I
Purification profile for preparation of E. coli 29–59 RNA ligase
Analysis of the RNA ligase activity at each step of the purification
process is shown. Yield was normalized to the S-100 supernatant,
where the highest amount of overall activity was observed, and the
comparative yield for crude extract is given in parentheses. ND, not
determined because total protein amounts unavailable.
Fraction Specific activity Purificationfactor Yield
fmol ligated/mg
protein/min
Crude extract 17.5 1 (77%)
S-100 Supernatant 22.8 1.3 100%
DEAE effluent 246.5 14 ND
Cellulose phosphate 1517 87 60%
Heparin Hyper-D 2381 136 37%
E. coli tRNA-Sepharose 2780 159 23%
Heparin Hyper-D (II) 5826 333 ND
Superdex 75 8606 492 23%
S. cerevisiae tRNA-Sepharose 18930 1082 17%
FIG. 2. Purification of the E. coli RNA ligase enzyme. Silver-
stained 16% SDS-PAGE gel of aliquots from individual purification
steps. Samples were normalized according to total fraction volume.
Lane 1, crude extract; lane 2, S-100 supernatant; lane 3, DEAE effluent;
lane 4, cellulose phosphate pool; lane 5, heparin hyper-D pool; lane 6, E.
coli tRNA-Sepharose pool; lane 7, heparin II pool; lane 8, Superdex 75
pool; lane 9, S. cerevisiae tRNA-Sepharose pool. The 20-kDa ligase
protein (identified as described under “Reconstitution of Ligase Activ-
ity”) is indicated on the right.
FIG. 3. Identification of the RNA ligase polypeptide. A, tRNATyr
half-molecule ligation assays containing 1 pmol of substrate were sup-
plemented with 2 ml of dialyzed gel slice eluates and incubated at 30 °C
for 30 min. Reactions supplemented with lane 1, buffer; lane 2, Super-
dex 75 activity pool; lane 3, eluate of ;3–12-kDa region of SDS-PAGE
gel lane; lane 4, eluate of 16-kDa region; lane 5, eluate of 20-kDa region;
lane 6, eluate of 27-kDa region; lane 7, eluate of 30-kDa region; lane 8,
eluate of; 35–100-kDa region of the gel lane. B, silver-stained 16%
SDS-PAGE gel of renatured elution fractions.M, molecular mass stand-
ards; lane 1, Superdex 75 activity pool; lane 2, bovine serum albumin;
lanes 3–8, same eluates as in A.
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ization to this blot (Fig. 4C) revealed two positive phage clones,
11C5 and 15A7, both mapping to the 3.0-min region of the E.
coli chromosome and containing about 10 kbp of overlapping
genomic DNA. Since sequencing of this genomic region had
recently been completed at the Institute for Viral Research in
Kyoto (25), the determined amino-terminal protein sequence
and 14 bp of unambiguous genomic DNA sequence were sub-
mitted for matching against their sequence data base. Exact
matches to both sequences were found in a theoretical ORF
located at 2.8 min on the E. coli chromosome, and these re-
searchers kindly provided the nucleotide sequence of a 3-kbp
region surrounding this ORF.
Analysis of the 29-59 RNA Ligase Gene—Theoretical transla-
tion of the DNA sequence of the ligase ORF predicts a protein
of 176 amino acids with a molecular mass of 19,934 Da (Fig.
5A). A methionine residue is encoded immediately prior to the
first residue of the amino-terminal sequence obtained from the
purified protein and is likely to be removed in vivo. A putative
Shine-Delgarno ribosomal recognition site is located 14 bp up-
stream of the RNA ligase ORF (Fig. 5A). A possible match to
the so-called “gearbox” transcriptional promoter consensus,
which is typically found upstream of genes whose expression is
inversely proportional to growth rate, can be found beginning
at 2119 upstream bp of the ORF (26). A possible ss 235 region
(often found without a 210 consensus), which may be recog-
nized by E. coli RNA polymerase bearing the stationary phase
sigma factor, can be seen at 2293 bp (27). The nearest potential
s70 housekeeping-type promoter consensus is found at 2749 bp
(not shown). Which promoter elements are utilized in vivo will
need to be determined experimentally.
The RNA ligase ORF is closely flanked by two other ORFs.
The previously characterized sfs1 gene (28) lies immediately
downstream of the ligase ORF with the same polarity and is
transcriptionally regulated by control elements that overlap
the ligase coding sequence (Fig. 5A). A theoretical ORF encod-
ing a putative RNA helicase of the DEAH family is found
immediately upstream of the RNA ligase ORF but with the
opposite polarity (25).
Comparison of the predicted RNA ligase protein sequence to
translations of the GenBank/EMBL data base using the
BLAST algorithm (29) identified two highly similar protein
sequences, predicted ORFs of unknown function fromMethano-
coccus jannaschii (30) and Bacillus stearothermophilus (31).
The E. coli, M. jannaschii, and B. stearothermophilus se-
quences are at least 23% identical and almost 50% similar over
the entire length of the E. coli ligase protein (Fig. 5B). The
Bacillus protein bears an extension of 129 amino acids at its
carboxyl terminus, but this additional sequence does not have
any significant matches in the available sequence data bases.
Alignment of the three sequences reveals three highly con-
served regions (a, b, and c in Fig. 5B) which may represent
important functional domains of these proteins.
Genomic Disruption of the RNA Ligase Gene—A genomic
disruption of the putative RNA ligase gene was performed in
order to confirm that the protein identified by purification of
RNA ligase activity was in fact the genuine ligase enzyme and
to observe any phenotypes caused by a lack of RNA ligase
function. The disruption was performed according to the
method of Hamilton et al. (22) utilizing homologous recombi-
nation and subsequent resolution of a temperature-sensitive
(ts) plasmid bearing an interrupted copy of the RNA ligase
gene. First, the ligase ORF and 200 bp of upstream flanking
sequence were amplified from genomic DNA using unique oli-
gonucleotide primers and cloned into the pBlueScript vector to
create the plasmid pBS-lig. A kanamycin resistance gene cas-
sette was inserted into a unique restriction site at 145 bp in
the ligase ORF, and the entire interrupted gene was subcloned
into a plasmid containing a ts replicon and chloramphenicol
resistance to create the plasmid pTSIL. After plasmid integra-
tion and resolution in a suitable RecA1 E. coli parent strain (as
described under “Experimental Procedures”), 64 candidate col-
onies were recovered. One of these was found to be both kana-
mycin-resistant and chloramphenicol-sensitive at 43 °C, indi-
cating stable chromosomal insertion. Insertion of the
kanamycin cassette into the correct chromosomal locus was
confirmed by PCR amplification of genomic DNA from individ-
ual colonies of the knockout isolate (Fig. 6A). Amplification
using primers hybridizing either 1 kbp upstream and at the 39
end of the ORF (set a) or at the 59 end of the ORF and 1.5 kbp
downstream (set b) gave a product which in the disrupted
isolates was increased by 1200 bp, precisely the size of this
cassette. When whole cell extracts of isolates of this knockout
strain were assayed for RNA ligase activity, none was detected
(Fig. 6B, compare lanes 3–5 with 6 and 7).
Ligase Knockout Growth—Effects of the disruption of RNA
ligase expression in E. coli on overall fitness were examined by
assaying bacterial growth under a variety of conditions. RNA
ligase knockouts were viable and showed wild-type growth
rates at temperatures ranging from 23 to 43 °C (not shown).
The growth curve of knockout isolates at 37 °C was essentially
identical to that of the parent strain (Fig. 7A). The effects of
moderate amounts of extra chromosomal expression of the 29-59
RNA ligase in knockout and wild-type strains were also tested.
E. coli strains were transformed with the pBS-lig construct
which fortuitously supported expression of RNA ligase activity
at approximately 10 times wild-type levels (as assayed by
measuring specific activity in whole cell extracts) but still at a
level of protein undetectable in crude extracts by SDS-PAGE
and silver staining (not shown). All RNA ligase overproducing
strains (Fig. 7B, B 1 D), but not those transformed with vector
alone (A 1 C), were temperature-sensitive, being viable at
37 °C but unable to grow at 43 °C. These overproducing strains
also showed a slow growth rate and reduced carrying capacity
at stationary phase at 37 °C, as shown in Fig. 7A. Thus, the
overproduction of E. coli RNA ligase has a toxic effect.
Enzyme Equilibrium—The equilibrium of the RNA ligation
FIG. 4. Detection of the RNA ligase gene. A, determined amino-
terminal amino acid sequence of 20-kDa ligase protein (large letters)
and corresponding degenerate oligonucleotides (small letters) synthe-
sized. B, PCR amplification of an E. coli genomic DNA fragment using
the oligonucleotides indicated in A as primers. PCR reactions were
separated on a 10% acrylamide gel and stained with ethidium bromide.
M, DNA molecular mass standards; lane 1, E. coli genomic DNA tem-
plate; lane 2, E. coli whole cells as template; lane 3, S. cerevisiae cells as
template; lane 4, primers omitted; lane 5, template omitted. C, the E.
coli genomic mapping blot hybridized with labeled PCR product created
using the degenerate oligonucleotide primers in A. Positive clones are
indicated by arrows.
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reaction was studied in vitro in order to gain insight into the in
vivo function of this enzyme. The time course of action of
purified E. coli RNA ligase on tRNATyr half-molecules and on
tRNATyr produced by ligation of tRNA half-molecules with E.
coli RNA ligase (creating a 29-59 linkage in the anticodon loop)
was assayed. tRNATyr produced by ligation of half-molecules
using T4 RNA ligase and PNK (to produce a 39-59 junction) was
also tested as a control. Fig. 8A shows that purified E. coli RNA
ligase specifically cleaved 29-59-linked substrates to fragments
comigrating with authentic Tyr half-molecules (lanes 0–5, E.
coli lig) with approximately the same kinetics as ligation of
half-molecules by that enzyme (lanes 0–5, Tyr 1/2’s). tRNATyr
with a 39-59 linkage at the ligation junction was not cleaved
(lanes 0–5, T4 lig.). The identity of the tRNA cleavage products
was confirmed by the ability of purified E. coli RNA ligase to
rejoin them, as demonstrated in Fig. 8A (E. coli dig.). Begin-
ning with either pure half-molecules or ligated tRNA, at 5 min
of incubation the molar ratio of substrates to products ap-
proached the same value (4–5:1, halves:full-length), as quan-
tified in Fig. 8C.
DISCUSSION
E. coli RNA Ligase Substrates—The results shown in Fig. 1
demonstrate that the E. coli 29-59 RNA ligase requires modified
nucleosides in artificial ligation substrates. This suggests that
the in vivo substrate(s) of this enzyme is modified and therefore
is likely to be a stable RNA as these modifications occur exclu-
sively in stable RNAs in E. coli (32). Modified nucleosides may
be recognized directly by the enzyme, as has been shown to
occur in the interactions between some tRNAs and tRNA ami-
noacyl synthetases (33), or these base modifications may be
required to stabilize the tRNA splicing substrates in a confor-
mation that can be recognized by this enzyme. Modified nucleo-
sides have been demonstrated to stabilize biologically active
conformers of tRNAs in other systems (34, 35). The apparent
requirement of E. coli 29-59 ligase for nucleoside modifications
FIG. 5. E. coli 2*-5* RNA ligase gene.
A, DNA sequence of the E. coli genomic
region including the RNA ligase gene,
with translations. Starts of ORFs encod-
ing a potential RNA helicase homolog and
the sfs1 gene are indicated. S-D, Shine-
Delgarno ribosome binding site. 235 and
210 5 consensus E. coli promoter se-
quences, gbox 235 and gbox 210, poten-
tial gearbox promoter consensus sequenc-
es; ss 235, potential stress-induced
promoter consensus sequence. B, align-
ment of E. coli RNA ligase protein se-
quence with potential homologs from
Methanococcus and Bacillus. Identical
residues are boxed in black and similar
residues are boxed in gray. The species of
origin of each ORF is indicated.
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and the preference shown by this enzyme for a subset of S.
cerevisiae tRNA splicing substrates suggest that the E. coli
ligase is likely to act upon a tRNA or tRNA-like molecule in
vivo. Comparison of the four S. cerevisiae tRNA species that are
ligated by the E. coli RNA ligase to the six that are not (8) does
not reveal any obvious consensus of sequence or base modifi-
cations that might be recognized. The preference of the E. coli
RNA ligase for yeast tRNATyr half-molecules over tRNAPhe
half-molecules (Fig. 1C) suggests that this enzyme has the
ability to discriminate among individual tRNA species.
Ligase Purification—Purification of the E. coli 29-59 RNA
ligase over 1000-fold from crude extracts provided highly puri-
fied protein fractions but not a single homogeneous polypep-
tide. Contaminating proteins remaining at the final stages of
purification probably represent molecules with properties very
similar to the 29-59 RNA ligase, but are not likely to be compo-
nents of a macromolecular complex as their concentrations
peak in different fractions during gel filtration (data not
shown). The tight binding of E. coli RNA ligase to immobilized
prokaryotic and eukaryotic tRNA provides additional evidence
that the ligase recognizes a tRNA or tRNA-like substrate in
vivo. The ability of the RNA ligase protein to refold and recon-
stitute enzymatic activity after SDS-PAGE suggests a stable,
self-folding structure for this protein.
Ligase Gene Sequence—Theoretical translation of the nucle-
otide sequence of the RNA ligase gene predicts a polypeptide
with size, charge, and other biochemical properties in excellent
agreement with those observed for the ligase protein. The li-
gase does not appear to be expressed as part of a multicistronic
operon as the nearest upstream ORF with the same polarity is
located about 12 kbp away, and the adjacent downstream ORF
(encoding the sfs1 protein) has its own promoter and regulatory
elements (28). The cis-acting sequences controlling RNA ligase
expression therefore remain to be determined.
The apparent conservation of the RNA ligase protein se-
quence between such distantly related bacterial species as E.
coli and B. stearothermophilus and across kingdoms to the
archaeote M. jannaschii suggests an ancient origin for this
enzyme. This is in agreement with the observation of RNA
ligase activity in extracts of a wide variety of bacterial species
(8). The short blocks of high similarity between these predicted
proteins as well as the lower dispersed similarity throughout
suggest that the alignment is meaningful and is likely to rep-
resent a homologous origin and function for these proteins. If
this alignment truly means that the 29-59 RNA ligase is highly
conserved between proteobacteria and Archaea, an important
metabolic function for this enzyme is implied.
The RNA ligase enzyme may have been lost from some evo-
lutionary branches between the low G 1 C Gram-positive bac-
teria and the Gamma division proteobacteria however, since
RNA ligase activity was not originally detected in Desulfu-
rovibrio, Paracoccus, or Rhodopseudomonas species, although
this may have been due to some artifact of extract preparation
or ligation assay (8). No obvious homolog to the 29-59 RNA
ligase protein can be found in the completed sequence of the H.
influenzae chromosome which, although closely related to E.
coli by rRNA sequence comparisons, has an extremely stream-
lined genome less than half the size of the chromosomes of
other proteobacteria (13). Haemophilus may have discarded
the ligase activity or transferred this function to another
polypeptide due to the selection pressures that caused the
FIG. 6. Genomic knockout of the RNA ligase gene. A, PCR am-
plification of ligase gene from various genomic DNA preparations. Prod-
ucts were separated on a 1.5% agarose gel and stained with ethidium
bromide. M, DNA molecular mass standards; lanes 1 and 5, HB101;
lanes 2 and 6, HS947 (knockout parent strain); lanes 3, 4, 7, and 8,
disrupted isolates. Set a, primers located 1-kbp upstream and at the 39
end of the ligase ORF; set B, primers located at the 59 end of the ligase
ORF and 1.5-kbp downstream. B, RNA ligation assay of lysates of
indicated strains. Ligation reactions including 500 fmol were incubated
at 30 °C for 10 min. Reactions supplemented with 1 ml each of the
following: lane 1, buffer; lane 2, purified E. coli RNA ligase (Superdex 75
pool); lanes 3–7, crude lysates of HB101 (lane 3), HS947 (lane 4), a
resolved cointegrate isolate not yet cured of the ts plasmid (lane 5),
disrupted, resolved isolates cured of plasmid (lanes 6 and 7).
FIG. 7. Growth phenotypes of RNA ligase knockout and over-
expressing strains. A, growth curves of E. coli strains at 37 °C derived
by viable plating of three replicate cultures of each. Shown are the
knockout parent strain HS947/RecA2 (E), HS947/RecA2 harboring the
RNA ligase expression plasmid pBS-lig (), an RNA ligase knockout
isolate (l), and a knockout harboring pBS-lig. (). Error bars represent
one standard deviation. B, growth of strains at indicated temperatures
on LB agar. A, HS947/RecA2; B, HS947/RecA2 1 pBS-lig.; C, RNA
ligase knockout; D, RNA ligase knockout 1 pBS-lig.
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drastic decrease in size of its genome. This would imply (as did
the lack of detectable activity in several bacterial species) that
the RNA ligase may not perform a function absolutely neces-
sary for bacterial survival but may be conditionally required
under growth conditions encountered by a wide variety of
species.
Genomic Disruption—Disuption of the genomic locus encod-
ing the putative ligase protein confirmed that the correct
polypeptide had been purified, since a complete loss of ligase
activity in cell extracts ensued. This protein therefore appears
to be the only enzyme in E. coli capable of ligating yeast tRNA
half-molecules. The fact that genomic ligase knockout isolates
were viable demonstrates that RNA ligase is not absolutely
required for survival under laboratory growth conditions. Al-
though the disrupted strains do not display a lethal phenotype,
they can be examined for more subtle effects on growth and
RNA metabolism. The availability of viable knockouts will also
provide a useful null background for the expression of affinity-
tagged or mutagenized ligase protein for use in further bio-
chemical experiments. The toxic effects of moderate levels of
ligase overexpression also imply some sort of interaction be-
tween the ligase enzyme and other cellular factors required for
growth.
Examination of Enzyme Equilibrium—The reaction cata-
lyzed by the E. coli ligase enzyme was shown to be fully revers-
ible with an apparent equilibrium constant near unity, but
favoring cleavage of 29-59 bonds. The tendency toward cleavage
may perhaps be explained by the thermodynamics of phos-
phodiester bond cleavage and formation, which have been in-
vestigated thoroughly in the hammerhead ribozyme system.
The favorable entropy of bond cleavage causes the internal
equilibrium of the hammerhead ribozyme to favor cleavage of
39-59 phosphodiesters to 29,39-cyclic phosphate and 59-hydroxyl
termini despite the unfavorable enthalpy associated with cyclic
phosphate formation (36). For the cleavage reaction catalyzed
by the E. coli RNA ligase, an increase of entropy in what is
essentially a unimolecular reaction (given the tight structural
association of tRNA half-molecules) may be due to the addi-
tional degrees of freedom available to released termini and to
the disruption of water ordered in and about the closed, struc-
tured anticodon loop.
This observed equilibrium of cleavage and ligation appears
to explain the maximum extent of ligation observed in in vitro
activity assays. However, it begs the question of whether the
function of the enzyme is to catalyze ligation or cleavage in
vivo. Despite the fact that the equilibrium observed in vitro
favors cleavage, the direction of the equilibrium in vivo will
depend on the effective concentrations of substrates available
for each reaction. If the true in vivo substrate is tRNA, and
ligated tRNA products are utilized for translation and thereby
removed from the pool of substrates available to the ligase,
then the ligation reaction will be favored. If, however, the
cleavage products are removed by some process such as ribo-
nucleolytic degradation, then the equilibrium will favor cleav-
age. To propose a cleavage function for the ligase enzyme in
vivo, however, it is necessary to posit a source of substrates
with 29-59 bonds, presumably in the context of a tRNA. No other
E. coli enzyme is known or proposed that might form internal
29-59 linkages in a tRNA structure. A variety of endoribonucle-
ase activities, however, could theoretically produce substrates
for ligation by the E. coli RNA ligase, and in fact an activity
FIG. 8. Equilibrium of the E. coli
RNA ligase. A, time course of forward
and reverse reactions of highly purified E.
coli RNA ligase. 4 ml of the Superdex 75
activity pool were added to 16 ml of the
reactions containing the substrates indi-
cated: Tyr 1⁄2’s, half-molecules derived
from T7-transcribed, yeast-modified pre-
tRNATyr (4 pmol), E. coli lig.tRNATyr,
tRNA produced by ligation of tRNATyr
half-molecules with purified E. coli 29-59
RNA ligase (0.8 pmol); T4 lig.tRNATyr,
tRNA produced by ligation of tRNATyr
half-molecules with T4 RNA ligase and
PNK in the presence of ATP (0.8 pmol).
4-ml aliquots were removed and stopped
at the indicated times. B, quantification
of the reactions in A, graphed according to
the molar ratio of full-length tRNA to
tRNA half-molecules at each time point.
Shown are tRNATyr half-molecules (f), E.
coli-ligated tRNATyr (), and T4-ligated
tRNATyr (E) substrates.
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capable of doing so has been observed in E. coli extracts.3 An
enzyme capable of cyclizing free 39-phosphates to 29,39-cyclic
phosphates has also recently been discovered in E. coli.4 Thus
the available evidence, while circumstantial, favors a ligation
function for this enzyme in vivo.
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